Aura Biosciences (AURA) Non-Current Assets (2020 - 2026)

Aura Biosciences' Non-Current Assets history runs 7 years deep, the most recent figure standing at $19.2 million for Q1 2026.

• Quarterly Non-Current Assets fell 8.19% year-over-year to $19.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.2 million (down 9.28% YoY) and the FY2025 annual result came in at $19.7 million, down 10.0% from the prior year.
• Non-Current Assets was $19.2 million for Q1 2026 at Aura Biosciences, down from $19.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $27.2 million in Q3 2022 and bottomed at $6.8 million in Q1 2022.
• A 5-year average of $21.2 million and a median of $21.9 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 330.49% — and 2024, when it slipped 15.53%.
• Aura Biosciences' Non-Current Assets stood at $27.2 million in 2022, then decreased by 14.51% to $23.3 million in 2023, then fell by 6.02% to $21.9 million in 2024, then declined by 10.0% to $19.7 million in 2025, then dropped by 2.63% to $19.2 million in 2026.
• Business Quant data shows AURA's Non-Current Assets at $19.2 million in Q1 2026, $19.7 million in Q4 2025, and $19.9 million in Q3 2025.